RA
ALZN icon

RFG Advisory’s Alzamend Neuro ALZN Stock Holding History

RFG Advisory’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-185
Closed -$6.57K – 733
2024
Q2 		$6.57K Hold
185
– – ﹤0.01% 699
2024
Q1 		$16.7K Hold
185
– – ﹤0.01% 710
2023
Q4 		$14.8K Hold
185
– – ﹤0.01% 644
2023
Q3 		$59.3K Hold
185
– – ﹤0.01% 616
2023
Q2 		$128K Hold
185
– – 0.01% 614
2023
Q1 		$106K Hold
185
– – 0.01% 615
2022
Q4 		$178K Hold
185
– – 0.01% 586
2022
Q3 		$270K Hold
185
– – 0.02% 512
2022
Q2 		$240K Hold
185
– – 0.01% 504
2022
Q1 		$308K Buy
+185
New +$347K 0.02% 412

Other funds holding ALZN

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
CSB
City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return

RFG Advisory's ALZN Position: Q3 2024 in Review

RFG Advisory sold out of Alzamend Neuro (ALZN) in Q3 2024, closing a stake of 185 shares — an estimated $6.57K sold.

RFG Advisory first reported a position in ALZN in Q1 2022 and held it in 10 quarters. The position peaked at $308K in Q1 2022. 9 funds tracked by Wall St. Rank hold ALZN as of Q3 2024.

  • RFG Advisory reported no remaining Alzamend Neuro position as of Q3 2024 after selling out during the quarter.
  • RFG Advisory sold 185 Alzamend Neuro shares in Q3 2024, an estimated $6.57K.
  • RFG Advisory first reported a position in Alzamend Neuro in Q1 2022 and held it in 10 quarters.
  • RFG Advisory's Alzamend Neuro position peaked at $308K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2024.

Based on RFG Advisory's 13F filing for Q3 2024, filed 17 Oct 2024.